Several biomarkers that are significantly associated with SM have been identified, including Angiopoietin-2, the ratio of Angiopoietin-2/Angiopoietin-1, soluble TREM-1 (sTREM-1), and specific host microRNAs, among others (10–12). The gene discussed is ANGPT2; the disease is systemic mastocytosis.